Psychiatry Annual Research Articles

Turning Oral Presentations at the Academy of Consultation-Liaison Psychiatry's Annual Meeting Into Published Articles: A Review and Analysis

Oral presentations at academic conferences typically describe recent or ongoing research projects or provide literature reviews. However, conversion of these presentations into full-length journal articles is not routine. We sought to assess the frequency with which oral presentations at the Academy of Consultation-Liaison Psychiatry's annual meetings from 2012 to 2018 were turned into peer-reviewed publications and review the factors that affected publication of them. Conferencepresentation titles and authors from the 2012-2018 Academy of Consultation-Liaison Psychiatry Annual Meetings were searched using PubMed to find corresponding published reports by the presenters. Data were organized in an Excel spreadsheet, and the time to publication, the journals in which they were published, and general content areas were recorded and analyzed. Of the 287 oral presentations delivered during the study period, 47% were published in a peer-reviewed journal. Articles were published in 72 different journals; the journals that published the most articles were Psychosomatics, General Hospital Psychiatry, Psycho-oncology, Academic Psychiatry, and the Journal of General Internal Medicine. The most common subspecialty topics of the published articles were neuropsychiatry, psycho-oncology, surgery and transplantation, and delirium. The mean time to publication after presentation was 1 year. Knowledge of the rate at which presentations are converted into peer-reviewed publications can be used to enhance the academic success of presenters, and strategies to enhance the rate of publication (e.g., by coaching on scientific writing or by selecting oral presentations with the highest publication potential) can be established.

Association between self-reported sleep quality and verbal learning in early stage clinically-stable schizophrenia outpatients

Oral presentations at academic conferences typically describe recent or ongoing research projects or provide literature reviews. However, conversion of these presentations into full-length journal articles is not routine.We sought to assess the frequency with which oral presentations at the Academy of Consultation-Liaison Psychiatry's annual meetings from 2012 to 2018 were turned into peer-reviewed publications and review the factors that affected publication of them.Conference presentation titles and authors from the 2012–2018 Academy of Consultation-Liaison Psychiatry Annual Meetings were searched using PubMed to find corresponding published reports by the presenters. Data were organized in an Excel spreadsheet, and the time to publication, the journals in which they were published, and general content areas were recorded and analyzed.Of the 287 oral presentations delivered during the study period, 47% were published in a peer-reviewed journal. Articles were published in 72 different journals; the journals that published the most articles were Psychosomatics, General Hospital Psychiatry, Psycho-oncology, Academic Psychiatry, and the Journal of General Internal Medicine. The most common subspecialty topics of the published articles were neuropsychiatry, psycho-oncology, surgery and transplantation, and delirium. The mean time to publication after presentation was 1 year.Knowledge of the rate at which presentations are converted into peer-reviewed publications can be used to enhance the academic success of presenters, and strategies to enhance the rate of publication (e.g., by coaching on scientific writing or by selecting oral presentations with the highest publication potential) can be established.

Gay and Gray Session: An Interdisciplinary Approach to Transgender Aging

With the overarching goals of improving the healthcare of older transgender individuals and of inspiring pertinent clinical research, a session at the 2017 American Association for Geriatric Psychiatry Annual Meeting focused on an interdisciplinary approach to transgender aging. The older the transgender adult, the more likely the individual grew up in a historical context when there was greater social stigma towards their gender identity, even among mental health professionals. In order to provide optimal healthcare to transgender adults, mental health care providers should become familiar with the basic terminology presented in this article. Transgender older adults face greater risks of poor physical health, disability, anxiety and depressive symptoms, victimization, and stigma, and higher rates of smoking, excessive alcohol use, and risky sexual behavior compared with non-transgender older adults. In spite of notable health disparities, some evidence points to resilience among transgender older adults. The mental health professional often serves as the first contact for a patient who is struggling with gender identity. The role of a mental health professional can be divided into five categories: 1) assessment of gender dysphoria; 2) psychoeducation of patients and family members about the diversity of gender identities and various options for alleviating gender dysphoria; 3) referral to and collaboration with other healthcare professionals; 4) treatment of coexisting mental health concerns; 5) advocating for transgender patients and for the transgender community. Recently, the criteria for medical and surgical transition have been simplified. End-of-life preparations are especially important for transgender individuals.

Liaison psychiatry professionals' views of general hospital care for patients with mental illness: The care of patients with mental illness in the general hospital setting

ObjectiveExplore the experiences of liaison psychiatry professionals, to gain a greater understanding of the quality of care patients with mental illness receive in the general hospital setting; the factors that affect the quality of care; and their insights on interventions that could improve care. MethodsA survey questionnaire and qualitative in depth interviews were used to collect data. Data collection took place at the Royal College of Psychiatrists Faculty of Liaison Psychiatry Annual conference. Qualitative analysis was done using thematic analysis. ResultsAreas of concern in the quality of care of patients with co-morbid mental illness included ‘diagnostic overshadowing’, ‘poor communication with patient’, ‘patient dignity not respected’ and ‘delay in investigation or treatment’. Eleven contributing factors were identified, the two most frequently mentioned were ‘stigmatising attitudes of staff towards patients with co-morbid mental illness’ and ‘complex diagnosis’. The general overview of care was positive with areas for improvement highlighted. Interventions suggested included ‘formal education’ and ‘changing the liaison psychiatry team’. ConclusionThe cases discussed highlighted several areas where the quality of care received by patients with co-morbid mental illness is lacking, the consequences of which could be contributing to physical health disparities. It was acknowledged that it is the dual responsibility of both the general hospital staff and liaison staff in improving care.

Improving quality and safety in inpatient CAMHS

British Journal of Mental Health NursingVol. 3, No. 4 CommentImproving quality and safety in inpatient CAMHSTim McDougallTim McDougallSearch for more papers by this authorTim McDougallPublished Online:29 Jul 2014https://doi.org/10.12968/bjmh.2014.3.4.148AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Green J, Jones D (1998) Unwanted effects of inpatient treatment: anticipation, prevention and repair. In Green J, Jacobs B, eds. Inpatient Psychiatry: Modern Practice, Research and the Future. Routledge, London Crossref, Google ScholarJacobs B, Green J, Beecham J et al. (2004) Children and Young Persons Inpatient Evaluation (CHYPIE): a prospective outcome study of inpatient child and adolescent psychiatry in England. Presented at the Royal College of Psychiatrists Faculty of Child and Adolescent Psychiatry Annual Residential Conference Google ScholarMassie L (2008) What Works?: Right Time, Right Place. National Service Framework Development Projects. Department of Health, London Google ScholarMcDougall T, Cotgrove A (2014) Specialist Mental Health Care for Children and Adolescents: Hospital, Intensive Community and Home Based Services. Routledge, London Google ScholarNHS England (2014) Child and Adolescent Mental Health Services (CAMHS) Tier 4 Report. Available at: www.england.nhs.uk/wp-content/uploads/2014/07/camhs-tier-4-rep.pdf (accessed 18 July 2014) Google ScholarRoyal College of Psychiatrists (2008) The Costs, Outcomes and Satisfaction for Inpatient Child and Adolescent Psychiatric Services (COSI-CAPS) Study. Royal College of Psychiatrists, London Google Scholar FiguresReferencesRelatedDetailsCited byNursing Children and Young People in Specialist CAMHS Inpatient Settings3 August 2019 2 July 2014Volume 3Issue 4ISSN (print): 2049-5919ISSN (online): 2052-496X Metrics History Published online 29 July 2014 Published in print 2 July 2014 Information© MA Healthcare LimitedPDF download

Emerging Concepts in Geriatric Psychiatry: an Update on the Canadian Academy of Geriatric Psychiatry Annual Scientific Meeting

-

The Institute of Medicine Report on the Mental Health and Substance Use Workforce for Older Adults: A Reflection

I chaired the Institute of Medicine (IOM) Committee on the Mental Health Workforce for Geriatric Populations and am a co-editor of the report, “The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands?”1 The report has been widely circulated, and a number of presentations at the most recent American Association for Geriatric Psychiatry annual meeting in Los Angeles were based on the report. It has also received attention in the popular press, including the New York Times.2 In addition, the report is readily available (free of charge) on the National Academies Press web site (http://www.nap.edu/topics.php?topic=395).

Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence

Emerging preclinical and clinical evidence suggests that pregnenolone may be a promising novel therapeutic candidate in schizophrenia. Pregnenolone is a neurosteroid with pleiotropic actions in rodents that include the enhancement of learning and memory, neuritic outgrowth, and myelination. Further, pregnenolone administration results in elevations in downstream neurosteroids such as allopregnanolone, a molecule with neuroprotective effects that also increases neurogenesis, decreases apoptosis and inflammation, modulates the hypothalamic-pituitary-adrenal axis, and markedly increases GABA(A) receptor responses. In addition, pregnenolone administration elevates pregnenolone sulfate, a neurosteroid that positively modulates NMDA receptors. There are thus multiple mechanistic possibilities for pregnenolone as a potential therapeutic agent in schizophrenia, including the amelioration of NMDA receptor hypofunction (via metabolism to pregnenolone sulfate) and the mitigation of GABA dysregulation (via metabolism to allopregnanolone). Additional evidence consistent with a therapeutic role for pregnenolone in schizophrenia includes neurosteroid changes following administration of certain antipsychotics in rodent models. For example, clozapine elevates pregnenolone levels in rat hippocampus, and these increases may potentially contribute to its superior antipsychotic efficacy [Marx et al. (2006a) Pharmacol Biochem Behav 84:598-608]. Further, pregnenolone levels appear to be altered in postmortem brain tissue from patients with schizophrenia compared to control subjects [Marx et al. (2006c) Neuropsychopharmacology 31:1249-1263], suggesting that neurosteroid changes may play a role in the neurobiology of this disorder and/or its treatment. Although clinical trial data utilizing pregnenolone as a therapeutic agent in schizophrenia are currently limited, initial findings are encouraging. Treatment with adjunctive pregnenolone significantly decreased negative symptoms in patients with schizophrenia or schizoaffective disorder in a pilot proof-of-concept randomized controlled trial, and elevations in pregnenolone and allopregnanolone post-treatment with this intervention were correlated with cognitive improvements [Marx et al. (2009) Neuropsychopharmacology 34:1885-1903]. Another pilot randomized controlled trial recently presented at a scientific meeting demonstrated significant improvements in negative symptoms, verbal memory, and attention following treatment with adjunctive pregnenolone, in addition to enduring effects in a small subset of patients receiving pregnenolone longer-term [Savitz (2010) Society of Biological Psychiatry Annual Meeting New Orleans, LA]. A third pilot clinical trial reported significantly decreased positive symptoms and extrapyramidal side effects following adjunctive pregnenolone, in addition to increased attention and working memory performance [Ritsner et al. (2010) J Clin Psychiatry 71:1351-1362]. Future efforts in larger cohorts will be required to investigate pregnenolone as a possible therapeutic candidate in schizophrenia, but early efforts are promising and merit further investigation. This article is part of a Special Issue entitled: Neuroactive Steroids: Focus on Human Brain.

Faculty of Child and Adolescent Psychiatry Annual Meeting 2002

Faculty of Child and Adolescent Psychiatry Annual Meeting 2002

Clarke Institute of Psychiatry Annual Research Fund Award

Clarke Institute of Psychiatry Annual Research Fund Award